Marine pharmacognosy Compounds from Marine Sources in Clinical Level Clinical Pipeline of Marine Pharmacology, July 2011. From http://marinepharmacology.midwestern.edu/clinPipeline.htm

| Clinical_Status | Compound_Name | Trademark | Marine_Organism_α | Chemical_Class | Molecular_Target | Clinical_Trials_β | Disease_Area |
|---|---|---|---|---|---|---|---|
| Phase III | Plitidepsin | Aplidin ® | Tunicate | Depsipeptide | Rac1 and JNK Activation | 1/7 | Cancer |
| Phase II | DMXBA (GTS-21) | N/A | Worm | Alkaloid | Alpha-7 Nicotinic Acetylcholine Receptor | 0/3 | Congnition , Schizophrenia |
| Phase II | Plinabulin (NPI 2358) | N/A | Fungus | Diketopiperazine | Microtubules and JNK Stress Protein | 1/2 | Cancer |
| Phase II | Elisidepsin | Irvalec ® | Mollusk | Depsipeptide | Plasma Membrane Fluidity | 1/2 | Cancer |
| Phase II | PM00104 | Zalypsis ® | Nudibranch | Alkaloid | DNA-Binding | 2/3 | Cancer |
| Phase II | Glembatumumab Vedotin (CDX-011) | N/A | Mollusk | Antibody Drug Conjugate (MM Auristatin E) | Glycoprotein NMB and Microtubules | 1/3 | Cancer |
| Phase I | Marizomib (Salinosporamide A) | N/A | Bacterium | Beta-Lactone-Gamma Lactam | 20S Proteasome | 4/4 | Cancer |
| Phase I | PM01183 | N/A | Tunicate | Alkaloid | Minor Groove of DNA | N/A | Cancer |